בייאטה 5 מק"ג

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Toimeaine:

EXENATIDE 250 MCG/ML

Saadav alates:

ASTRA ZENECA ISRAEL LTD

ATC kood:

A10BX04

Ravimvorm:

SOLUTION FOR INJECTION

Manustamisviis:

S.C

Valmistatud:

LILLY PHARMA FERT. & DISTRIB. GmbH & Co. KG

Terapeutiline rühm:

EXENATIDE

Näidustused:

Byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.Byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Loa andmise kuupäev:

2013-01-01